Security key
432705309
Canton Strategic Holdings, Inc. - Common stock, $0.0001 par value (CNTN)
CUSIP: 432705309
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common stock, $0.0001 par value
- Total 13F shares
- 24,257
- Total 13F value
- $60,157
- Share change
- +18,076
- SEC-reported price per share
- $2.46
- Number of holders
- 4
- Value change
- +$39,400
- Number of buys
- 2
- Number of sells
- 2
- Shares outstanding
- 62,099,339
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q3 2024
Institutions
4
Top holders
4
CNTN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Canton Strategic Holdings, Inc. SEC filings
Canton Strategic Holdings, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 432705309
Recent filing periods:
Ownership snapshot
Top reported holders of CNTN - Canton Strategic Holdings, Inc. - Common stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
UBS Group AG
Disclosed value leader
Highpoint Pharmaceuticals...
Comparable rows
4/11
Latest evidence
09 Aug 2024
13F
3/4/5
Lead comparable stake: 0.01%
7 rows are not safely comparable across share classes.
Showing 1-6 of 11 holder rows.
Quick read
UBS Group AG leads the comparable SEC ownership view at 0.01%.
4 of 11 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 4
UBS Group AG
0.01%
Tower Research Capital LLC (TRC)
0%
BANK OF AMERICA CORP /DE/
0%
JPMORGAN CHASE & CO
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 11 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UBS Group AG |
13F
Company
|
0.01%
|
$18,250
5,170 shares
|
— | 30 Jun 2024 |
| Tower Research Capital LLC (TRC) |
13F
Company
|
0%
|
$3,544
1,004 shares
|
— | 30 Jun 2024 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0%
|
$21
6 shares
|
— | 30 Jun 2024 |
| JPMORGAN CHASE & CO |
13F
Company
|
0%
|
$4
1 shares
|
— | 30 Jun 2024 |
| Highpoint Pharmaceuticals LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$489,028
972,222 shares
|
— | 11 Jan 2022 |
| Kufe LLC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$407,629
810,395 shares
|
— | 11 Jan 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
4
Shares
24,257
Rows available
4
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
4
Q3 2024 holders
4
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend